NCT06542900View on ClinicalTrials.gov

Efficacy of Deep Brain Stimulation(DBS) for Treatment-Resistant Depression(TRD)

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 10, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Treatment Resistant Depression
Interventions
DEVICE

Deep Brain Stimulation (DBS)

The DBS lead is stereotactically introduced into the target in the brain (SCC, VC/VS, ALIC, ITP, NAc, LHb, MFB, or other unreported nuclei targets) and fixed to the skull; the lead is then connected to a neurostimulator implanted subcutaneously in the subclavicular region.

Trial Locations (1)

100053

Xuanwu Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Xuanwu Hospital, Beijing

OTHER

NCT06542900 - Efficacy of Deep Brain Stimulation(DBS) for Treatment-Resistant Depression(TRD) | Biotech Hunter | Biotech Hunter